Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2002-12-16 (23 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PEZENAS (34120), Herault
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE GARCIAS : revenue, balance sheet and financial ratios
SELARL PHARMACIE GARCIAS is a French company
founded 23 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PEZENAS (34120),
this company of category PME
shows in 2024 a net income positive of 199 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE GARCIAS (SIREN 444537476)
Indicator
2024
2023
2021
2020
2019
2018
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
198 639 €
173 593 €
350 381 €
368 123 €
270 023 €
237 883 €
283 299 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE GARCIAS generates positive net income of 199 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 283 k€ -> 199 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
198 639 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 9%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
8.549%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
66.331%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2023
2024
Debt ratio
655.729
158.913
86.998
67.176
28.323
19.796
8.549
Financial autonomy
9.608
28.413
38.733
43.652
55.789
62.003
66.331
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
8.552024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent
In 2024, the debt ratio of SELARL PHARMACIE GARCIAS (8.55) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
66.33%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+7 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE GARCIAS (66.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 164.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2020
2021
2023
2024
Liquidity ratio
144.423
123.878
114.68
161.589
153.145
176.38
164.701
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
164.72024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average+10 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE GARCIAS (164.70) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE GARCIAS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE GARCIAS is estimated at
2 773 147 €
(range 1 931 175€ - 4 148 787€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1931k€2773k€4148k€
2 773 147 €Range: 1 931 175€ - 4 148 787€
NAF 5 année 2024
Valuation method used
Net Income Multiple
198 639 €
×
14.0x
=2 773 147 €
Range: 1 931 176€ - 4 148 787€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE GARCIAS with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE GARCIAS
What is the revenue of SELARL PHARMACIE GARCIAS ?
The revenue of SELARL PHARMACIE GARCIAS is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE GARCIAS profitable?
Yes, SELARL PHARMACIE GARCIAS generated a net profit of 199 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE GARCIAS ?
The headquarters of SELARL PHARMACIE GARCIAS is located in PEZENAS (34120), in the department Herault.
Where to find the tax return of SELARL PHARMACIE GARCIAS ?
The tax return of SELARL PHARMACIE GARCIAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE GARCIAS operate?
SELARL PHARMACIE GARCIAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart